The emergency medicine, Buccolam®, made by ViroPharma, has recently been given European approval for treating long-lasting seizures. Buccolam® is licensed for use in children and young people between the ages of three months and 18 years. Buccolam® comes in four ready-filled syringes, each suitable for different age groups.
Although other versions of buccal midazolam are available, Buccolam® is the first one to be licensed.